7712-28-9,MFCD01820403
Catalog No.:AA008NWU

7712-28-9 | 3-(3-Oxo-3,4-dihydro-quinoxalin-2-yl)-propionic acid

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
95%
in stock  
$75.00   $53.00
- +
5g
95%
in stock  
$186.00   $130.00
- +
10g
95%
in stock  
$345.00   $242.00
- +
25g
95%
in stock  
$678.00   $475.00
- +
100g
95%
in stock  
$1,567.00 $1,097.00
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA008NWU
Chemical Name:
3-(3-Oxo-3,4-dihydro-quinoxalin-2-yl)-propionic acid
CAS Number:
7712-28-9
Molecular Formula:
C11H10N2O3
Molecular Weight:
218.2087
MDL Number:
MFCD01820403
SMILES:
OC(=O)CCc1nc2ccccc2[nH]c1=O
Properties
Computed Properties
 
Complexity:
338  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
16  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0  
Rotatable Bond Count:
3  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
0.1  

Downstream Synthesis Route

[1]JournaloftheChemicalSociety,1922,vol.121,p.664

[1]BioorganicandMedicinalChemistryLetters,2019,vol.29,p.2197-2202

[2]EuropeanJournalofMedicinalChemistry,2020,vol.188

[3]TetrahedronLetters,2008,vol.49,p.1053-1056

[4]Patent:CN108997230,2018,A.Locationinpatent:Paragraph0100;0101;0102

[5]Molecules,2000,vol.5,p.358-359

[6]Molecules,2000,vol.5,p.358-359

[7]Actapoloniaepharmaceutica,2009,vol.66,p.169-172

7712-28-9   
3-(3-hydrazone-3,4-dihydro-quinoxalin-2-yl)propionicacid 

[1]Actapoloniaepharmaceutica,2009,vol.66,p.169-172

7712-28-9   
ethyl3-(3-(4-phenoxyphenoxy)quinoxalin-2-yl)propanoate 

[1]Patent:CN108997230,2018,A

Literature

Title: Ethyl 3-(3-oxo-3,4-dihydro-quinoxalin-2-yl)propano-ate.

Journal: Acta crystallographica. Section E, Structure reports online 20101201

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Title: Synthesis of hydrazones derivatives of quinoxalinone--prospective antimicrobial and antiinflammatory agents.

Journal: Acta poloniae pharmaceutica 20090101

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:7712-28-9 Molecular Formula|7712-28-9 MDL|7712-28-9 SMILES|7712-28-9 3-(3-Oxo-3,4-dihydro-quinoxalin-2-yl)-propionic acid
Catalog No.: AA008NWU
7712-28-9,MFCD01820403
7712-28-9 | 3-(3-Oxo-3,4-dihydro-quinoxalin-2-yl)-propionic acid
Pack Size: 1g
Purity: 95%
in stock
$75.00 $53.00
Pack Size: 5g
Purity: 95%
in stock
$186.00 $130.00
Pack Size: 10g
Purity: 95%
in stock
$345.00 $242.00
Pack Size: 25g
Purity: 95%
in stock
$678.00 $475.00
Pack Size: 100g
Purity: 95%
in stock
$1,567.00 $1,097.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA008NWU
Chemical Name: 3-(3-Oxo-3,4-dihydro-quinoxalin-2-yl)-propionic acid
CAS Number: 7712-28-9
Molecular Formula: C11H10N2O3
Molecular Weight: 218.2087
MDL Number: MFCD01820403
SMILES: OC(=O)CCc1nc2ccccc2[nH]c1=O
Properties
Complexity: 338  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 16  
Hydrogen Bond Acceptor Count: 4  
Hydrogen Bond Donor Count: 2  
Isotope Atom Count: 0  
Rotatable Bond Count: 3  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 0.1  
Downstream Synthesis Route
328-50-7    39145-59-0    7712-28-9 

[1]JournaloftheChemicalSociety,1922,vol.121,p.664

328-50-7    95-54-5    7712-28-9 

[1]BioorganicandMedicinalChemistryLetters,2019,vol.29,p.2197-2202

[2]EuropeanJournalofMedicinalChemistry,2020,vol.188

[3]TetrahedronLetters,2008,vol.49,p.1053-1056

[4]Patent:CN108997230,2018,A.Locationinpatent:Paragraph0100;0101;0102

[5]Molecules,2000,vol.5,p.358-359

[6]Molecules,2000,vol.5,p.358-359

[7]Actapoloniaepharmaceutica,2009,vol.66,p.169-172

7712-28-9   
3-(3-hydrazone-3,4-dihydro-quinoxalin-2-yl)propionicacid 

[1]Actapoloniaepharmaceutica,2009,vol.66,p.169-172

7712-28-9   
ethyl3-(3-(4-phenoxyphenoxy)quinoxalin-2-yl)propanoate 

[1]Patent:CN108997230,2018,A

Literature fold

Title: Ethyl 3-(3-oxo-3,4-dihydro-quinoxalin-2-yl)propano-ate.

Journal: Acta crystallographica. Section E, Structure reports online20101201

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters20101101

Title: Synthesis of hydrazones derivatives of quinoxalinone--prospective antimicrobial and antiinflammatory agents.

Journal: Acta poloniae pharmaceutica20090101

Building Blocks More >
76014-82-9
76014-82-9
4-(Methylnitrosamino)-1-(3-pyridyl-N-oxide)-1-butanone
AA008OOW | MFCD01320423
74696-96-1
74696-96-1
3-Acetyl-7-(diethylamino)-2h-chromen-2-one
AA008P7A | MFCD00068687
7382-41-4
7382-41-4
2-(4-Chlorophenyl)hydrazinecarbothioamide
AA008PUP | MFCD00456275
7358-93-2
7358-93-2
3-Cyclopropylprop-2-ynoic acid
AA008QJW | MFCD03035228
1180-95-6
1180-95-6
Taurodeoxycholic acid sodium salt
AA008R0N | MFCD00003671
109760-77-2
109760-77-2
D,L-ERYTHRO-1-PHENYL-2-DECANOYLAMINO-3-MORPHOLINO-1-PROPANOL HCL
AA008RA3 | MFCD08703011
1184540-14-4
1184540-14-4
3-Boc-3-ethylaminopiperidine
AA008RL1 | MFCD12155464
105807-83-8
105807-83-8
7-Amino-2,2-dimethyl-2H-benzo[b][1,4]oxazin-3(4H)-one
AA008RSV | MFCD11048439
10488-87-6
10488-87-6
Ethyl 2-methyl-3-oxo-3-phenylpropanoate
AA008S0N | MFCD00026882
106981-56-0
106981-56-0
4-(2,5-Dimethyl-1H-pyrrol-1-yl)-3-methoxyaniline
AA008S95 | MFCD02194731
Submit
© 2017 AA BLOCKS, INC. All rights reserved.